HomeCompareASBFF vs JNJ

ASBFF vs JNJ: Dividend Comparison 2026

ASBFF yields 3.65% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASBFF wins by $1109.58M in total portfolio value
10 years
ASBFF
ASBFF
● Live price
3.65%
Share price
$23.18
Annual div
$0.84
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1109.61M
Annual income
$1,054,057,854.58
Full ASBFF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ASBFF vs JNJ

📍 ASBFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASBFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASBFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASBFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASBFF
Annual income on $10K today (after 15% tax)
$309.85/yr
After 10yr DRIP, annual income (after tax)
$895,949,176.39/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ASBFF beats the other by $895,945,190.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASBFF + JNJ for your $10,000?

ASBFF: 50%JNJ: 50%
100% JNJ50/50100% ASBFF
Portfolio after 10yr
$554.82M
Annual income
$527,031,271.99/yr
Blended yield
94.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ASBFF
No analyst data
Altman Z
4.5
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASBFF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASBFFJNJ
Forward yield3.65%2.13%
Annual dividend / share$0.84$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$1109.61M$30.3K
Annual income after 10y$1,054,057,854.58$4,689.40
Total dividends collected$1105.59M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASBFF vs JNJ ($10,000, DRIP)

YearASBFF PortfolioASBFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,429$729.07$10,592$272.30+$837.00ASBFF
2$13,787$1,557.49$11,289$357.73+$2.5KASBFF
3$18,263$3,511.70$12,123$472.89+$6.1KASBFF
4$28,237$8,695.36$13,141$629.86+$15.1KASBFF
5$55,343$25,128.92$14,408$846.81+$40.9KASBFF
6$151,274$92,057.52$16,021$1,151.60+$135.3KASBFF
7$632,202$470,338.17$18,122$1,588.22+$614.1KASBFF
8$4,350,524$3,674,068.15$20,930$2,228.20+$4.33MASBFF
9$51,913,505$47,258,444.77$24,792$3,191.91+$51.89MASBFF
10$1,109,605,305$1,054,057,854.58$30,274$4,689.40+$1109.58MASBFF

ASBFF vs JNJ: Complete Analysis 2026

ASBFFStock

Associated British Foods plc operates as a diversified food, ingredients, and retail company worldwide. It operates through five segments: Grocery, Sugar, Agriculture, Ingredients, and Retail. The Grocery segment manufactures and sells grocery products, including hot beverages, sugar and sweeteners, vegetable oils, balsamic vinegars, bread and baked goods, cereals, ethnic foods, and meat products to retail, wholesale, and foodservice businesses. The Sugar segment is involved in growing, processing, and selling sugar beet and sugar cane to industrial users. The Agriculture segment manufactures and sells animal feeds; and provides other products and services for the agriculture sector. The Ingredients segment manufactures bakers' yeast, bakery ingredients, enzymes, lipids, yeast extracts, and cereal specialties. The Retail segment is involved in buying and merchandising clothing and accessories through the Primark and Penneys retail chains, which offer womenswear, menswear, kids wear, accessories, homeware, and beauty products. The company was incorporated in 1934 and is headquartered in London, the United Kingdom. Associated British Foods plc is a subsidiary of Wittington Investments Limited.

Full ASBFF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ASBFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASBFF vs SCHDASBFF vs JEPIASBFF vs OASBFF vs KOASBFF vs MAINASBFF vs ABBVASBFF vs MRKASBFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.